NewAmsterdam Pharma NAMS Q1 2026 Earnings EPS Beat Reflects Cost Management Amid PreRevenue Phase Veralto Corp VLTO Q1 2026 Earnings Earnings Beat Driven by Operational Strength Stock Moderately Higher ALGM Q1 2026 Earnings EPS Beats Estimates by Nearly 2 Amidst Revenue Uncertainty ACXP Q1 2026 Earnings Narrowed Loss Surprises as Acurx Advances Lead Candidate DSGR Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower Nuburu Q3 2023 Earnings Narrowed Loss and Strategic Progress Drive Sentiment